News Sentiment

QGEN sentiment intelligence

Qiagen NV news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 61 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 41.51 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 61

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+4.5% over one week, +13.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Is Rising Cyclospora Testing Demand Reframing Qiagen’s Infectious Disease Strategy (QGEN)?

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction 4.5% Price confirming higher
Trend fit Trend inactive 13.0% over four weeks
Fair value -4.6% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 34
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 61
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
ad-hoc-news.de 9
MarketBeat 7
Investing.com 6
Market source 5
simplywall.st 4
Stock Titan 4
Moomoo 4
TradingView 3

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 11
Analyst action 11
Macro sensitivity 4
Deals and strategy 3
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 61
MarketBeat Direct company coverage

Y Intercept Hong Kong Ltd Buys Shares of 34,485 Qiagen N.V. $QGEN

Y Intercept Hong Kong Ltd initiated a new position in Qiagen N.V. during the first quarter, acquiring 34,485 shares valued at approximately $1.38 million. Qiagen, which has seen other institutional investors also adjust their holdings, holds a consensus "Hold" rating from analyst

Tone
Neutral 50/100
Event
Analyst action
Published
11 Jul 2026 15:39
Source
MarketBeat
MarketBeat Direct company coverage

Waterfront Wealth Inc. Makes New $1.05 Million Investment in Qiagen N.V. $QGEN

Waterfront Wealth Inc. has made a new $1.05 million investment in Qiagen N.V. during the first quarter, acquiring 26,221 shares. Other institutional investors have also increased their stakes, bringing the total institutional ownership to 70%. Qiagen recently reported an EPS of $

Tone
Positive 67/100
Event
Earnings
Published
11 Jul 2026 14:39
Source
MarketBeat
TradingView Direct company coverage

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG

QIAGEN N.V. announced a release regarding voting rights according to Article 40, Section 1 of the WpHG, following a notification from the Netherlands Authority For the Financial Markets (AFM). The notification indicates that Millennium International Management LP holds approximat

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 08:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of QIAGEN NV – AQUISEU:QIAD

This article provides financial data for QIAGEN NV (QIAD) on the Aquis Stock Exchange, specifically focusing on its enterprise value to revenue forward. The content is sparse, mainly showing the financial metric's period, value, and change, without further analysis or context.

Tone
Neutral 50/100
Event
Earnings
Published
11 Jul 2026 05:11
Source
TradingView
GuruFocus Direct company coverage

Qiagen NV (QGEN) Stock Up 10.5% and Still Undervalued -- GF Scor

Qiagen NV (QGEN) saw its stock rise by 10.5% to $41.99, yet GuruFocus's GF Value™ suggests it remains "Modestly Undervalued" with a fair value of $52.67. The company boasts an above-average GF Score™ of 69/100, driven by strong valuation and profitability, despite concerns regard

Tone
Positive 72/100
Event
Market update
Published
09 Jul 2026 22:41
Source
GuruFocus
Moomoo Direct company coverage

QIAGEN Rallies on Renewed Takeover Interest

QIAGEN's stock rallied significant interest following reports of renewed takeover bids. This resurgence in acquisition talks indicates strong market confidence in the biotechnology company's value. The potential for a buyout is driving investor optimism and increasing the company

Tone
Positive 77/100
Event
Deals and strategy
Published
09 Jul 2026 20:39
Source
Moomoo
Moomoo Direct company coverage

Market Chatter: Private Equity Firms Reportedly Circle Molecular Testing Company Qiagen

Private equity firms are reportedly interested in acquiring Qiagen, a molecular testing company, causing its stock (QGEN) to rise by 10.50%. This news briefly mentions Unity Software's Q4 earnings, where revenue increased 35% year-over-year to $609 million, beating estimates, des

Tone
Positive 65/100
Event
Earnings
Published
09 Jul 2026 16:41
Source
Moomoo
Reuters Direct company coverage

EQT, Advent, KKR explore takeover of diagnostics firm Qiagen, Bloomberg News reports

Diagnostics company Qiagen is reportedly attracting takeover interest from buyout firms EQT, Advent, and KKR, with potential offers of at least $50 per share. Qiagen's shares rose substantially on the news, although no final decisions have been made. The report follows earlier ne

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 16:21
Source
Reuters
citybiz Direct company coverage

Qiagen Shares Jump on Report of Takeover Interest from EQT, Advent, KKR

Qiagen N.V. (NYSE: QGEN) saw its shares climb approximately 11% following reports that private equity firms, including EQT AB, Advent, and KKR, have expressed early takeover interest. The molecular diagnostics company, which maintains a significant presence in Germantown, Marylan

Tone
Positive 72/100
Event
Market update
Published
09 Jul 2026 16:21
Source
citybiz
SRN News Direct company coverage

Qiagen draws early takeover interest from EQT, Advent & KKR, Bloomberg News reports

Diagnostics company Qiagen is reportedly attracting takeover interest from buyout firms including EQT AB, Advent, and KKR, with potential offers reaching at least $50 per share. This news, initially reported by Bloomberg, caused Qiagen's shares in Frankfurt to rise by at least 10

Tone
Positive 81/100
Event
Market update
Published
09 Jul 2026 15:21
Source
SRN News
MarketBeat Direct company coverage

Investors Purchase High Volume of Qiagen Call Options (NYSE:QGEN)

Investors recently purchased a high volume of call options for Qiagen (NYSE:QGEN), with Thursday seeing 4,493 calls bought, representing a 261% increase over the average. This unusual options activity coincided with a 12.5% jump in the stock price to $42.75 on heavy trading volum

Tone
Positive 65/100
Event
Market update
Published
09 Jul 2026 15:21
Source
MarketBeat